← AVANOS MEDICAL, INC.
| Annual Trend | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $1.6b | $611.6m | $652.3m | $697.6m | $714.8m | $744.6m | $820.0m | $673.3m | $687.8m | $701.2m | |
| Cost of Revenue | $1.0b | $274.7m | $261.4m | $295.4m | $341.5m | $380.3m | $370.0m | $293.6m | $306.5m | $347.3m | |
| Gross Profit | $557.9m | $336.9m | $390.9m | $402.2m | $373.3m | $364.3m | $450.0m | $379.7m | $381.3m | $353.9m | |
| Operating expenses: | |||||||||||
| Operating Income (Loss) | $87.4m | ($43.1m) | $500k | ($55.7m) | ($46.1m) | $8.9m | $74.0m | $4.2m | ($396.2m) | ($61.6m) | |
| Additional Financial Items | |||||||||||
| Amortization of Intangible Assets | $22.0m | $21.0m | $20.0m | $20.0m | $19.4m | $16.7m | $25.7m | $24.3m | $25.2m | $19.2m | |
| Goodwill, Impairment Loss | $0 | $0 | — | — | — | — | — | — | — | $77.0m | |
| Income (Loss) from Continuing Operations before Income Taxes, Domestic | $24.2m | ($76.2m) | ($20.7m) | ($61.8m) | ($50.8m) | $2.8m | $59.3m | ($17.3m) | ($421.5m) | ($82.8m) | |
| Income (Loss) from Continuing Operations, Per Basic Share | ($2) | ($1) | ($0) | ($1) | ($1) | ($1) | $0 | ($0) | ($8) | ($2) | |
| Income (Loss) from Continuing Operations, Per Diluted Share | ($2) | ($1) | ($0) | ($1) | ($1) | ($1) | $0 | ($0) | ($8) | ($2) | |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | $55.3m | ($72.2m) | ($18.1m) | ($64.0m) | ($60.5m) | $5.8m | $65.2m | ($7.9m) | ($403.3m) | ($66.2m) | |
| Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent | $83.3m | ($32.1m) | ($8.5m) | ($45.9m) | ($27.2m) | $30.9m | $21.5m | ($9.9m) | ($386.3m) | ($72.9m) | |
| Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Parent | $123.1m | $111.4m | $66.0m | $0 | $0 | $37.2m | $29.0m | ($51.9m) | ($5.8m) | $0 | |
| Net Income (Loss) Attributable to Parent | $39.8m | $79.3m | $57.5m | ($45.9m) | ($27.2m) | $5.2m | $50.5m | ($61.8m) | ($392.1m) | ($72.9m) | |
| Earnings Per Share, Basic | $0.85 | $1.69 | $1.22 | ($0.96) | ($0.57) | $0.11 | $1.08 | ($1.32) | ($8.53) | ($1.57) | |
| Earnings Per Share, Diluted | $0.85 | $1.69 | $1.22 | ($0.96) | ($0.57) | $0.11 | $1.07 | ($1.32) | ($8.53) | ($1.57) | |
| Weighted Average Number of Shares Outstanding, Basic | 46.6m | 46.8m | 47.2m | 47.6m | 47.8m | 48.1m | 46.9m | 46.6m | 46.0m | 46.3m | |
| Weighted Average Number of Shares Outstanding, Diluted | 47.0m | 46.8m | 47.2m | 47.6m | 47.8m | 48.6m | 47.3m | 46.6m | 46.0m | 46.3m | |
| Research and Development Expense | $41.1m | $38.2m | $41.8m | $37.7m | $34.9m | $32.3m | $30.6m | $27.2m | $26.2m | $23.3m | |
| Selling, General and Administrative Expense | $411.1m | $321.7m | $340.4m | $399.1m | $332.6m | $300.3m | $341.9m | $335.0m | $318.5m | $315.6m | |
| Interest Expense (non-operating) | — | — | — | — | — | — | — | — | $12.2m | $7.8m | |
| Current Income Tax Expense (Benefit) | $42.0m | ($30.6m) | ($13.3m) | ($3.1m) | ($44.9m) | ($2.9m) | $18.4m | $10.1m | $18.9m | $14.5m | |
| Interest Expense | $32.7m | $31.6m | $26.4m | $15.0m | $15.6m | $3.3m | $10.0m | $15.0m | $12.2m | $7.8m | |
| Income Tax Expense (Benefit) | $15.5m | ($40.1m) | ($9.6m) | ($18.1m) | ($33.3m) | $600k | $14.7m | $2.0m | ($17.0m) | $6.7m | |
| Other Operating Income (Expense), Net | ($18.3m) | ($20.1m) | ($8.2m) | ($21.1m) | ($51.9m) | ($22.8m) | ($3.5m) | ($13.3m) | $3.9m | $400k |
Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.